p75ECD as a Biomarker

Biosensis Nerve growth factor receptor, extracellular domain (NGFR/p75ECD) ELISA kits (Human and Mouse)

p75ECD as a Biomarker


The p75 neurotrophin receptor extracellular domain (p75ECD) is a fragment shed from the p75 neurotrophin receptor, a protein involved in a literal cornucopia of functions, including its role in cell death, survival, scar formation, energy expenditure, hypoxic response, tissue repair, metabolism, and neurodegeneration. 

Research suggests that p75ECD levels in biofluids like urine may be a biomarker for several neurological diseases, particularly Amyotrophic Lateral Sclerosis (ALS). Studies show significantly higher urinary p75ECD levels in ALS patients compared to healthy controls and those with other neurological conditions. p75ECD levels might correlate with disease progression, with higher levels potentially indicating a faster decline. Baseline p75ECD levels might offer prognostic information on patient survival independent of other clinical parameters.


Biosensis' NGFR/p75ECD ELISA Kits are designed to quantify nerve growth factor receptor extracellular domain fragments in urine. Biosensis offers NGFR/p75ECD ELISA kits engineered explicitly for human or mouse samples, and our kits are highly sensitive. With a broad detection range (62.5 - 4,000 pg/mL) and high sensitivity (< 50 pg/mL), they provide accurate insights even at low concentrations. The comprehensive kits include pre-coated strip plates, standards, QC samples, and detailed protocols. Convenient storage at 2-8°C enhances kit longevity. 

BEK-2239-1P

(Human)

BEK-2220-1P

(Mouse)

Our Product Citations for p75ECD ELISA

Covarrubias C et al. (2023) Decrease in the Ratio proBDNF/BDNF in the Urine of Aging Female Patients with OAB Metabolites. 2023 Jun; 13(6): 723. Application: Human, Urine.


Yamada S et al. (2021) Ratio of urinary N-terminal titin fragment to urinary creatinine is a novel biomarker for amyotrophic lateral sclerosis   J Neurol Neurosurgeon Psychiatry 92(10):1072-1079 Application: Human Urine.


Luu BE et al. (2022) Modulation of diabetic kidney disease markers by an antagonist of p75NTR in streptozotocin-treated mice Gene. 2022 Sep 5:838:146729. Application: Mouse plasma.


Maejima H et al. (2018) Exercise enhances cognitive function and neurotrophin expression in the hippocampus accompanied by changes in epigenetic programming in senescence-accelerated mice. Neurosci Lett. 2018 Feb 5:665:67-73. Application: Mouse hippocampus homogenates.


Zabbarova IV et al. (2018) Targeting p75 neurotrophin receptors ameliorates spinal cord injury-induced detrusor sphincter dyssynergia in mice. Neurourol Urodyn. 2018 Nov;37(8):2452-2461. Application: Mouse urine.


From NGFR/p75-ECD ELISAs to p75NTR Antibodies Biosensis has your p75 research needs covered

Explore all p75 products here

Biosensis is a company that is passionate about Science

LinkedIn  X  YouTube